ARCHIVES

Guest Editorial: Even Slam-Dunk Applications Can Benefit From Public Scrutiny and Discussion at ODAC

This article is from The Cancer Letter archive.

Vol. 38 No. 32 | August 10, 2012

Download PDF Visit The Full Archive

Related Articles

NCCS Networker Volume 3 Issue 2, Spring 1989

April 13, 1989

Also Lance Armstrong visits NIH, Washington, for Tour of Hope event.

October 17, 2003

NCI Opens Negotiations With Litton-Bionetics For Renewal of $10 Million Frederick Contract

March 1, 1974

More Concept Approvals By DCPC Board

May 18, 1984

Revlimid Maintenance Therapy Delayed Progression by 90%

May 27, 2011

NeoRx Suspends Accrual, Treatment In Phase III trial Using STR For Myeloma.

December 1, 2000